Hematology – Erythrocyte Morphology
Codocytes (target cells)
Codocytes — also called target cells, target erythrocytes, or referred to by the English term target cells — are red blood cells with abnormal morphology observed in a blood smear stained with May-Grünwald-Giemsa, characterized by a very distinctive appearance resembling a shooting target or a bull’s-eye: a central zone of hemoglobin density surrounded by a pale, achromatic ring, which is itself encircled by a thin, dense peripheral rim. This appearance of three concentric zones results from a change in the membrane surface area-to-erythrocyte volume ratio: any relative increase in the surface area of the plasma membrane relative to the cell volume—or, conversely, any reduction in intracellular hemoglobin content—forces the excess membrane to fold into concentric domes during smear preparation, producing the characteristic target-like appearance of the cell. The mechanism may therefore be membrane-related (excess membrane lipids in cholestatic liver diseases) or intracellular (deficiency of functional hemoglobin in thalassemias, presence of structurally abnormal hemoglobins in hemoglobinopathies). The presence of codocytes on a blood smear is never normal in adults outside the context of a postsplenectomy, where their appearance is expected and physiological in the absence of the spleen, whose erythrocyte remodeling function normally eliminates red blood cells with excess membrane. Their detection systematically points toward a targeted etiological workup based on the clinical context, complete blood count (CBC) data, and any other associated erythrocyte morphological abnormalities observed on the smear. The main causes of clinically significant codocytosis fall into three broad categories: thalassemias and hemoglobinopathies (sickle cell disease, hemoglobin C, hemoglobin E), chronic liver diseases with cholestasis, and severe iron deficiency—each with distinct pathophysiological mechanisms, associated laboratory findings, and management approaches.
Codocyte formation mechanism
The formation of a codocyte is based on an imbalance between the red blood cell's membrane surface and its volume, which can occur through two main complementary mechanisms:
- Membrane mechanism - lipid excess of the membrane: In cholestatic liver diseases, hypercholesterolemia and increased circulating phospholipids allow their incorporation into the erythrocyte membrane lipid bilayer, increasing membrane surface area without altering cell volume; the excess membrane folds into domes and forms the characteristic target cells on slide preparations; these codocytes are normochromic (normal intracellular hemoglobin level) and normocytic.
- Intracellular mechanism — deficiency in functional hemoglobin: in thalassemias and hemoglobinopathies, hemoglobin synthesis is reduced (thalassemias) or the hemoglobin structure is abnormal (HbC, HbE, HbS), leading to a decrease in mean corpuscular hemoglobin concentration (MCHC); the cell volume is proportionally reduced, but the membrane surface remains in relative excess, producing the same target cell appearance; these codocytes are typically hypochromic and microcytic
- Post-splenectomy represents a third mechanism: the spleen normally and continuously removes red blood cells with excess membrane by «trimming» their membrane as they pass through the splenic cords of Billroth; in the absence of the spleen, erythrocytes with excess membrane are no longer removed and persist in circulation, leading to the appearance of codocytes, acanthocytes, and other poikilocytes after surgical splenectomy or functional asplenia.
- Practically, the distinction between these mechanisms relies on clinical context, MCV (mean corpuscular volume), MCHC, and other CBC parameters: normocytic normochromic codocytosis points towards liver disease or post-splenectomy, while microcytic hypochromic codocytosis suggests thalassemia or hemoglobinopathy.
Main causes of codocytosis
Codocytes are observed in a specific range of clinical situations. Their presence on a smear is a signal pointing towards specific diagnostic entities:
| Cause | Codocytosis mechanism | Clinical context and associated anomalies |
|---|---|---|
| Thalassemias (alpha and beta) | Deficit in the synthesis of globin chains, reducing intracellular hemoglobin concentration; increased surface area to volume ratio due to microcytosis and hypochromia | Frequent and abundant codocytosis, associated with marked microcytosis and hypochromia (low MCV, low MCHC), anemia of variable severity according to genotype; frequent presence of other morphological abnormalities: poikilocytosis, basophilic stippling, circulating erythroblasts in severe forms; diagnosis by hemoglobin electrophoresis (increased HbA2 in beta-thalassemia) and molecular genetic analysis |
| Hemoglobin C (HbC) homozygous or compound heterozygous SC | HbC (Glu→Lys substitution at position 6 of the beta chain) crystallizes in the red blood cell, reducing cell volume and creating an increased surface-to-volume ratio. | Frequent and abundant codocytes (the most numerous codocytes of all hemoglobinopathies) with sometimes intraglobular HbC crystals visible on the smear; moderate chronic hemolytic anemia in the homozygous CC form; SC form (HbS + HbC): moderate sickle cell disease with less frequent vaso-occlusive crises but significant retinal complications |
| Homozygous or heterozygous Hemoglobin E (HbE) | HbE (Glu→Lys substitution at position 26 of the beta chain) produces an unstable hemoglobin with reduced synthesis, behaving like beta-thalassemia minor. | Very frequent in Southeast Asia; marked microcytosis with abundant codocytes, but mild to moderate anemia in the homozygous EE form; HbE/beta-thalassemia double heterozygosity is one of the most severe forms of beta-thalassemia worldwide |
| Sickle cell disease (HbSS) and AS heterozygosity | Hemoglobin S polymerizes in the deoxy state, deforming the red blood cell into a sickle shape; codocytes are less characteristic than in HbC but can be present, particularly during depolymerization. | The sickle cell smear is primarily characterized by sickle cells (sickle-shaped cells), Howell-Jolly bodies (functional asplenia), and Howell cells; codocytes are an accessory finding in sickle cell smears. |
| Cholestatic liver diseases (biliary cirrhosis, PBC, drug-induced cholestasis) | Excess of membrane lipids by enrichment of the red blood cell bilayer in cholesterol and phosphatidylcholine; increase in membrane surface area at constant volume | Normochromic normocytic red blood cells without microcytic anemia; other possible abnormalities: acanthocytes (spur cells, Spur cells) in advanced cirrhosis, stomatocytes; abnormal liver function tests with predominantly elevated alkaline phosphatase and GGT |
| Severe non-cholestatic liver diseases (alcoholic cirrhosis, fulminant hepatitis) | Disruption of hepatic lipid metabolism with altered erythrocyte membrane lipid composition | Codocytes are often less numerous than in pure cholestasis; the smear is dominated by acanthocytes in advanced alcoholic cirrhosis (severe acute alcoholic hepatitis); frequent associated macrocytosis (high MCV) linked to folate deficiency and the direct effect of alcohol. |
| Severe iron deficiency | Major reduction in intracellular hemoglobin concentration due to iron deficiency, increasing surface area to volume ratio | Codocytes associated with marked microcytosis and hypochromia, anisocytosis and poikilocytosis, and sometimes with annnulocytes (red blood cells almost devoid of hemoglobin); low ferritin, low serum iron, low transferrin saturation coefficient; low reticulocytes (central anemia due to deficiency). |
| Post-splenectomy and functional asplenia | Absence of splenic remodeling of excess membrane erythrocytes; persistence in circulation of normally cleared red blood cells | Codocytes characteristically associated with Howell-Jolly bodies (residual nuclear inclusions normally removed by the spleen), acanthocytes, and reactive thrombocytosis; context of prior surgical splenectomy or functional asplenia (sickle cell disease, celiac disease, amyloidosis) |
| Sideroblastic anemia | Failure to use iron for hemoglobin synthesis despite normal or elevated iron stores; iron accumulation in erythroblast mitochondria (ring sideroblasts) | Dimorphic smear (coexistence of normal and hypochromic microcytic red blood cells); codocytes among hypochromic red blood cells; elevated ferritin, elevated transferrin saturation coefficient; bone marrow aspirate with Prussian blue stain essential for diagnosis |
ℹ️
The presence of codocytes on a blood smear never constitutes a diagnosis in itself, but rather a morphological sign pointing towards a range of pathologies that need to be clarified by the clinical context and targeted investigations. The number of codocytes, their association with other morphological abnormalities (sickle cells, acanthocytes, basophilic stippling, Howell-Jolly bodies), and the results of the complete blood count (MCV, MCHC, reticulocytes) are the key elements for diagnostic orientation. Outside of the post-splenectomy context, any documented codocytosis requires an etiological workup.
Associated anomalies on the smear according to context
Codocytes are rarely seen in isolation on a blood smear and are often accompanied by other morphological abnormalities. The combination of these abnormalities constitutes an erythrocyte signature that strongly guides the diagnosis:
| Morphological association | Main diagnostic orientation |
|---|---|
| Codocytes + basophilic stippling + circulating erythroblasts + microcytosis hypochromia | Intermediate or major thalassemia (beta-thalassemia); the severity of these abnormalities is proportional to the severity of the thalassemic genotype |
| Abundant codocytes + hexagonal rod-shaped intraglobular crystals | Hemoglobin C disease, homozygous (HbCC); HbC crystals are pathognomonic and visible on peripheral blood smears after red blood cell dehydration. |
| Codocytes + sickle cells + Howell-Jolly bodies | Sickle cell SC (HbSC) or sickle cell SS with established functional asplenia |
| Normochromic codocytes + acanthocytes (spur cells) + macrocytosis | Advanced hepatopathy (alcoholic cirrhosis, severe acute alcoholic hepatitis); acanthocytes indicate severe impairment of hepatic lipid metabolism |
| Codocytes + Howell-Jolly bodies + reactive thrombocytosis | Post-splenectomy or functional asplenia (sickle cell disease, celiac disease, splenic amyloidosis); thrombocytosis is characteristic and can be marked (> 600 to 800 G/L) |
| Codocytes + annulocytes + severe hypochromic microcytosis | Severe iron deficiency; annulocytes (red blood cells almost empty of hemoglobin, donut appearance) indicate very iron-deficient erythropoiesis |
| Normochromic codocytes + stomatocytes | Cholestatic hepatopathy, particularly extrahepatic cholestasis or chronic cholestatic diseases; stomatocytes (central slit instead of central depression) often coexist with codocytes in hepatopathies |
Diagnostic approach for codocytosis
The discovery of codocytes on a blood smear guides a structured, step-by-step diagnostic approach, guided by the clinical context and CBC data:
- First step — characterize the red blood cell profile of the CBC: MCV (macrocytosis, normocytosis, or microcytosis), MCHC (normochromia or hypochromia), reticulocyte count (central or peripheral anemia), platelet count (thrombocytosis suggesting asplenia)
- Second step – targeted questioning: personal or family history of hemolytic anemia, hemoglobinopathy, or thalassemia; ethnic origin (beta-thalassemia common in the Mediterranean region, HbC in West Africa, HbE in Southeast Asia); history of splenectomy or disease that can cause functional asplenia; signs of liver disease (alcohol consumption, known viral hepatitis, cholestasis)
- Third step — initial biological assessment: complete liver function tests (AST, ALT, GGT, alkaline phosphatase, total and conjugated bilirubin, PT, albumin) for normochromic codocytes; iron studies (ferritin, serum iron, total iron-binding capacity, transferrin saturation) for hypochromic microcytic codocytes; HPLC hemoglobin electrophoresis for any presentation suggestive of hemoglobinopathy or thalassemia
- Fourth stage—specialized investigations according to orientation: molecular genetic study of globin genes (alpha and beta) if thalassemia is confirmed; liver biopsy or magnetic resonance cholangiopancreatography if chronic cholestatic liver disease is suspected; bone marrow aspiration with Perl's stain if sideroblastic anemia is suggested; hematology consultation for complex hemoglobinopathies
Role of blood smear in hematological evaluation
The peripheral blood smear remains a fundamental examination in hematology, with an irreplaceable diagnostic value for the morphological characterization of red blood cells:
- It is systematically prescribed in the presence of anemia not explained by the complete blood count alone, an abnormality of red blood cell indices suggestive of abnormal morphology, or clinical suspicion of hemoglobinopathy or thalassemia.
- The smear is made on fresh blood collected in EDTA, spread manually on a glass slide or by an automated analyzer, then stained with May-Grünwald-Giemsa; it is read by a hematologist or a technician specialized in morphological hematology.
- Modern hematology analyzers detect and flag morphological alarms (presence of abnormal cells, atypical red blood cell populations) but do not replace the human review of a quality smear for the identification of codocytes, sickle cells, schistocytes, or other specific poikilocytes.
- The international nomenclature recommends the term «codocyte» (from Greek codeine poppy head, whose shape resembles a target cell seen from the side) although the terms «target cell» and target cell remain in common use in clinical practice and in biological reports
- The quantification of codocytes on the smear is semi-quantitative: rare (1 to 2 per field), moderate (3 to 10 per field), or abundant (>10 per field); a codocyte percentage exceeding 25% of red blood cells is highly suggestive of hemoglobin C or major thalassemia
ℹ️
In Quebec, thalassemia and hemoglobinopathies primarily affect populations of Mediterranean (Italian, Greek, Portuguese), Sub-Saharan African (HbS, HbC), Caribbean, Middle Eastern, and Southeast Asian (HbE, alpha-thalassemia) origin—communities well represented in the Montreal region. The discovery of codocytes with microcytosis and hypochromia without iron deficiency in a patient of these origins should systematically lead to hemoglobin electrophoresis by HPLC, an examination available in the majority of Quebec hospital laboratories, to avoid missing a thalassemia or hemoglobinopathy transmissible to offspring.
Situations requiring rapid hematologic evaluation
The presence of abundant codocytes on a blood smear, associated with severe anemia (hemoglobin less than 70 g/L), jaundice, splenomegaly, or a history of vaso-occlusive crises in a child or young adult, requires immediate hematological consultation to confirm or rule out severe hemoglobinopathy (sickle cell disease, thalassemia major) and to initiate appropriate management. In the context of known liver disease, the appearance of codocytes associated with abundant acanthocytes may signal worsening hepatocellular insufficiency, warranting urgent hepatological re-evaluation. Furthermore, any individual considering pregnancy with a personal or family history of thalassemia or hemoglobinopathy should undergo genetic counseling before conception.
For any blood smear abnormalities, biological results suggestive of hemoglobinopathy or thalassemia, or hematological evaluation requiring specialized orientation, Clinique Omicron offers structured medical consultations at its service points in Quebec and via telemedicine. To book an appointment, visit cliniqueomicron.ca.
Consult at Clinique Omicron
Clinique Omicron supports patients in exploring anemia, interpreting blood smear abnormalities, and connecting them with specialized hematology resources at its service points in Quebec and through telemedicine. A physician or Nurse Practitioner (NP) can order a complete hematological workup, including a complete blood count (CBC), blood smear, iron studies, and hemoglobin electrophoresis, interpret the results within their clinical context, and coordinate a referral to a hematologist or medical geneticist based on the identified abnormalities. To book an appointment, visit cliniqueomicron.ca.
The content of this page is provided for informational purposes only and does not substitute the advice of a qualified healthcare professional. Consult a doctor for any hematological abnormalities, abnormal blood smear results, or persistent anemia symptoms.
Omicron Clinic
Need to consult a doctor?
Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.
Insurance receipts. 7j/7. No family doctor required.